The consumer goods giant reported stronger-than-expected Q4 results, citing growth across key metrics despite inflationary pressures. As it rolls out its ambitious 2030 growth plan, management warns of a volatile global operating environment in the year ahead.
Shares of marketing software firm Zeta Global have tumbled over 10% in a week, sparking debate among investors. While a key valuation model suggests the stock is significantly undervalued, market sentiment remains cautious amid broader tech volatility.
Citi analyst Geoff Meacham raised his price target on Bristol-Myers Squibb (BMY) to $60, citing a more favorable setup for the sector. The move comes as the drugmaker also announces a partnership with Microsoft to leverage AI for earlier lung cancer detection.
Private equity giant Thoma Bravo is exploring a sale of Imprivata, a key player in healthcare digital identity software, in a deal that could value the company at up to $7 billion, sources tell Reuters.
NextEra Energy's unique dual-business model offers investors the stability of a regulated utility alongside the high-growth potential of its renewable energy arm, positioning it as a key player in powering the AI boom.
As Palantir Technologies prepares to report Q4 results, options markets signal significant volatility ahead, with the stock's AI-driven rally facing a reality check amid shifting investor focus.
Iran’s foreign minister says missile programme not up for negotiation as Trump says sending more ships to the region.
U.S. stocks extended losses into a third session as investors weighed the potential implications of Kevin Warsh's nomination to lead the Federal Reserve, capping a volatile week of trading.
RBC Capital reaffirms its Outperform rating on UnitedHealth Group, citing management's commitment to long-term earnings targets, even as a lower-than-expected Medicare Advantage rate proposal triggers a sharp sell-off in the health insurer's shares.
A prominent crypto analyst warns that Bitcoin could retest a critical long-term support level near $57,000, signaling a deepening correction as the digital asset market stumbles into 2026.
SoFi CEO Anthony Noto calls the Powell Fed era a mixed bag, praising the ultimate economic stability despite policy stumbles. As the baton passes to a new Treasury Secretary, investors weigh SoFi's record growth against a cautious 2026 outlook.
ARK Invest CEO Cathie Wood argues the parabolic rise in gold, not artificial intelligence, represents the current asset bubble, pointing to its recent sharp correction as validation of her view while reaffirming her bullish stance on Bitcoin.
Five years after its meme-stock frenzy, GameStop is aiming for a colossal acquisition to transform its business. CEO Ryan Cohen could earn a $35 billion payday if he succeeds in reaching a $100 billion market cap—a goal experts call wildly ambitious.
Tunisian President Kais Saied has prolonged the nation's state of emergency for an additional 11 months, maintaining exceptional powers first enacted in 2015 following a deadly attack on presidential guards.
President Trump's reported selection of former Fed Governor Kevin Warsh to lead the central bank signals a potential shift in monetary policy approach, with a focus on strategic foresight over data-dependency, according to economist Mohamed El-Erian.
Shares of Heidelberg Materials have delivered stellar returns, more than tripling over three years. As the stock consolidates near recent highs, investors are questioning whether the rally has priced in future growth or if significant value remains. A deep dive into valuation metrics suggests the latter.
Barrick Gold's stock has soared over 220% in the past year, leaving investors to question if the rally has peaked. A deep dive into valuation metrics suggests the mining giant may still be trading at a significant discount to its intrinsic value.
With National Australia Bank shares surging nearly 120% over five years, investors are questioning whether the current price around A$43.37 still offers value. Our analysis reveals a mixed picture: while some metrics suggest the stock is fairly valued, others point to potential upside.
Truist Securities adjusted its price target for American Healthcare REIT (NYSE: AHR) downward slightly, while affirming a Buy rating. The move comes as the firm reassesses its outlook for the broader REIT sector heading into 2026.
Analyst Quinn Bolton of Needham maintains a Buy rating on D-Wave Quantum (QBTS), highlighting the company's strengthened competitive position after its acquisition of Quantum Circuits, which creates the world's only dual-platform quantum computing firm.
